Back to Search
CHRISTOPHER SINGH, MD
MD
Ophthalmology Physician
NPI: 1083724900IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
0433684(KS)MD00045533(WA)2009008676(MO)4301089275(MI)
Education
SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE
Class of 2003
Research & Publications (20)
Assignment of Brevibacterium stationis (ZoBell and Upham 1944) Breed 1953 to the genus Corynebacterium, as Corynebacterium stationis comb. nov., and emended description of the genus Corynebacterium to include isolates that can alkalinize citrate.
PMID 19661509·Int J Syst Evol Microbiol·2010
8-other
Histiocytic corona around a glomeruloid intrafollicular polyp of the thyroid.
PMID 19666945·Int J Surg Pathol·2009
5-case
Orally active 1,2,4-trioxepanes: synthesis and antimalarial activity of a series of 7-arylvinyl-1,2,4-trioxepanes against multidrug-resistant Plasmodium yoelii in Swiss mice.
PMID 18054238·Bioorg Med Chem·2008
7-preclinical
Orally active esters of dihydroartemisinin: Synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in mice.
PMID 18206370·Bioorg Med Chem Lett·2008
7-preclinical
New functionalized 1,2,4-trioxepanes: synthesis and antimalarial activity against multi-drug resistant P. yoelii in mice.
PMID 18789862·Bioorg Med Chem Lett·2008
7-preclinical
Studies on the removal of Pb(II) from wastewater by activated carbon developed from Tamarind wood activated with sulphuric acid.
PMID 17889434·J Hazard Mater·2008
8-other
Hypervalent iodine(III)-mediated regioselective N-acylation of 1,3-disubstituted thioureas.
PMID 18318545·J Org Chem·2008
8-other
Novel bis- and tris-1,2,4-trioxanes: synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice.
PMID 19006381·J Med Chem·2008
7-preclinical
Orally active antimalarials: synthesis and bioevaluation of a new series of steroid-based 1,2,4-trioxanes against multi-drug resistant malaria in mice.
PMID 17548195·Bioorg Med Chem Lett·2007
7-preclinical
New adamantane-based spiro 1,2,4-trioxanes orally effective against rodent and simian malaria.
PMID 17266204·J Med Chem·2007
7-preclinical
Entropy-mediated patterning of surfactant-coated nanoparticles and surfaces.
PMID 18233304·Phys Rev Lett·2007
8-other
Conversion of antimalarial drug artemisinin to a new series of tricyclic 1,2,4-trioxanes1.
PMID 17877363·Org Lett·2007
8-other
8-(1-Naphthalen-2-yl-vinyl)-6,7,10-trioxaspiro (4.5) decane, a new 1,2,4-trioxane effective against rodent and simian malaria.
PMID 16275088·Bioorg Med Chem Lett·2006
7-preclinical
It is "thiazolidene-2-imine" and not imidazole-2-thione as the reaction product of 1-benzoyl-3-phenylthiourea with Br(2)/enolizable ketone.
PMID 17078727·Org Lett·2006
8-other
Orally active 1,2,4-trioxanes: synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5]undecanes against multi-drug-resistant plasmodium yoelii nigeriensis in mice.
PMID 16640340·J Med Chem·2006
7-preclinical
Synthesis of 1,2,4-trioxepanes and 1,2,4-trioxocanes via photooxygenation of homoallylic alcohols.
PMID 17109530·J Org Chem·2006
8-other
New orally active derivatives of artemisinin with high efficacy against multidrug-resistant malaria in mice.
PMID 17125275·J Med Chem·2006
7-preclinical
New orally active spiro 1,2,4-trioxanes with high antimalarial potency.
PMID 16105737·Bioorg Med Chem Lett·2005
7-preclinical
Protection of the carbonyl group as 1,2,4-trioxane and its regeneration under basic conditions.
PMID 16321019·Org Lett·2005
8-other
Synthesis of new 6-alkylvinyl/arylalkylvinyl substituted 1,2,4-trioxanes active against multidrug-resistant malaria in mice.
PMID 15465332·Bioorg Med Chem·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 5885 S MAIN ST, STE 2
CLARKSTON, MI 48346 - Phone
- (810) 487-4500
Quick Facts
- NPI
- 1083724900
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 3
- Years in Practice
- 23
- Publications
- 20
Are you this provider?
Claim Your Profile